RedHill Biopharma (RDHL) Exchange Rate Effect (2012 - 2022)
RedHill Biopharma's (RDHL) quarterly Exchange Rate Effect came in at -$16000.0 in Q4 2022, down 277.78% year-on-year from $9000.0 in Q4 2021, and down 23.08% on a QoQ basis from -$13000.0 in Q3 2022.
RedHill Biopharma (RDHL) Exchange Rate Effect (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has 11 years of Exchange Rate Effect data on file, last reported at -$16000.0 in Q4 2022.
- On a quarterly basis, Exchange Rate Effect fell 277.78% year-over-year to -$16000.0 in Q4 2022; TTM through Dec 2022 was -$76000.0, a 21.65% increase from a year earlier, with the FY2025 full-year figure at -$2000.0, down 122.22% from the prior year.
- Exchange Rate Effect for Q4 2022 stood at -$16000.0, down from -$13000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for RDHL reached as high as $131000.0 in Q1 2020 and fell as low as -$103000.0 in Q1 2021.
- Historically, Exchange Rate Effect has averaged -$2650.0 across 5 years, with a median of -$13500.0 in 2018.
- On a YoY basis, Exchange Rate Effect climbed as much as 718.75% in 2020 and fell as far as 3400.0% in 2020.
- Year by year, Exchange Rate Effect stood at -$16000.0 in 2018, then soared by 437.5% to $54000.0 in 2019, then plunged by 83.33% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then plunged by 277.78% to -$16000.0 in 2022.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$16000.0 in Q4 2022, -$13000.0 in Q3 2022, and -$32000.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -16,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | -17,000.00 |
| Sep 30, 2021 | -17,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Mar 31, 2021 | -103,000.00 |
| Mar 31, 2021 | -103,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | -33,000.00 |
| Sep 30, 2020 | -33,000.00 |